Twitter Facebook LinkedIn YouTube

New Listing: IM Cannabis Corp. (CSE:IMCC)

Video Platform Video Management Video Solutions Video Player

The company is an international medical cannabis company, and a well-known Israeli brand of medical cannabis products.

Additional Information:

Company: IM Cannabis Corp.
Stock Symbol: CSE: IMCC
Date Published: Nov 6, 2019
Transcript: Available

Video Transcript:

I’m Cassandra Bolinski for Investmentpitch Media

IM Cannabis Corp. is one of the latest new listings on the Canadian Securities Exchange, trading under the symbol “IMCC”, having previously traded as Navasota Resources on the TSX Venture Exchange.

The company is an international medical cannabis company, and a well-known Israeli brand of medical
cannabis products.

In Europe, the company is establishing a fully operational, vertically integrated medical cannabis business spearheaded by its distribution arm in Germany and augmented by strategic agreements with certified EU-GMP Standard suppliers, making it one of the only medical cannabis companies with fully integrated operations in Europe.

Its core Israeli business includes offering branding, know-how and other intellectual property related
services to the Israeli medical cannabis market.

Its key assets in Israel include commercial agreements with licensed producers and an option to purchase licensed entities.

The company has designed and developed a unique conveyor system, in its packing facility that moves the raw materials along a track automatically.

This proprietary automatic system saves time, expenses and manpower, enabling it to produce higher quality medical cannabis products at a faster rate and very competitive price making it one of the world’s most advanced cannabis cultivators.

In order to guarantee absolute safety and quality of products, Israeli cannabis growers are required to obtain Good Agricultural Practice or GAP certification which is based on strict quality management standards and production practices and is granted after passing strict audits.

The company is one of only four LP’s to have received GAP certification.

As Israeli GAP standards are highly respected globally, management expects this certification will give the company a significant competitive advantage.

Oren Shuster, CEO, stated: "The team at IMC has done exceptionally well to position the Company as a market leader in the EU. Against a backdrop of challenging capital market conditions in the cannabis industry, investors have recognized the team's stellar operating history in the medical cannabis sector, recognized its potential and have bought into its European expansion strategy, which now includes operations in Germany, a supply agreement in Europe, and will soon include operations in Portugal and Greece as well. We have been active in the research and development ecosystem for cannabis technologies in Israel and expect to make further announcements regarding these efforts in the near term.”

The company recently raised gross proceeds of $20.4 million from the placement of 19.4 million units priced at $1.05 per unit.

Each unit consisted of one share and one-half a warrant, with each full warrant exercisable at $1.30 for 24 months.

The shares are trading at $0.55.

For more information, please visit the company’s website contact Oren Shuster, CEO, at 972-77-3603504 or by email at

Investor Relations is handled by Marc Charbin at LodeRock Advisors, who can be reached at 416-467-5229 or email

I’m Cassandra Bolinski for Investmentpitch Media